November 30, 2004
Clinical Trials Update: Nov. 30, 2004
(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch:
Please see http://www.centerwatch.com/patient/studies/cat111.html.
A research study testing whether insulin glargine and omega-3 fatty acids can prevent future cardiovascular disease and associated complications. Volunteers 50 or older who have any of these risk factors may be eligible: a blood-sugar level that is slightly high, type 2 diabetes treated by a maximum of one pill, a previous heart attack or stroke, stable or unstable angina, or other diseases of the heart or blood vessels. Research site located in Los Angeles, Calif.
Please see http://www.centerwatch.com/patient/studies/cat213.html.
A research study of an investigational medication for dyspepsia. Volunteers 18 or older who have active dyspepsia symptoms may be eligible to participate in this 9-week study. Research site located in Dallas, TX.
Please see http://www.centerwatch.com/patient/studies/cat310.html.
Copyright 2004 CenterWatch. All rights reserved.